Pursuing a transformative cancer treatment with the goal of delivering immune cell therapy faster and more effectively
CEO & Co-founder
Gunsoo Kim, is the Chief Executive Officer and Co-Founder of Curocell. He is responsible for overall strategic and operational leadership of all research and development activities and translation development initiatives in cell therapy. He has nearly 20 years of research and development as well as strategic planning experience in the pharma industry. Together with his leading experience in the field, Gunsoo plays a pivotal role in bringing the innovative cell therapy into reality.
Chan Hyuk Kim, Ph.D.
Chan Hyuk Kim, Ph.D., is the Chief Technical Officer and Co-Founder of Curocell and an assistant professor in the department of Biological Sciences at Korea Advanced Institute of Science and Technology(KAIST). He has in-depth knowledge and research experiences in the field of immuno-oncology and cancer immunotherapy. Prior to his current position, he was a principal investigator at California Institute for Biomedical Research(Calibr), US, where he led several cancer immunotherapy projects, including a prostate cancer-specific bispecific antibody and a switchable CAR-T platform. Recently, Calibr announced the partnership with AbbVie for the commercial development of the switchable CAR-T technology.
Hyunbo Shim, Ph.D.
Hyunbo Shim, PhD., is the Chief Scientific Officer and Co-Founder of Curocell, overseeing discovery of novel scFv for the development of CAR-T cell therapy. He has been highly acclaimed for his work in antibody discovery, engineering and optimization. Currently he is an associate professor of Life Science at Ewha Womans University in Seoul, Korea. Prior to Ewha, he was a research scientist at XOMA corp, a US-based biotech. His antibody library technology has been licensed to 10+ biotech and pharmaceutical companies and is one of the most widely adopted antibody discovery platform in Korea. Hyunbo earned his B.S. And M.S. in Chemistry from Seoul National University, and Ph.D. from Texas A&M University. He was also a postdoctoral associate at the laboratory of the late Carlos F. Barbas III at the Scripps Research Institute in La Jolla, California.